SATURACIÓN DE LA OXIHEMOGLOBINA Y RELACIÓN VENTRÍCULO DERECHO/VENTRÍCULO TOTAL (VD/VT) EN DOS LÍNEAS COMERCIALES DE POLLOS DE CARNE CRIADOS A NIVEL DEL MAR

The study aimed to determine the relationship between body weight, oxyhemoglobin saturation and right ventricle/total ventricle ratio (VD/VT) in two commercial broiler lines raised at sea level. It was used 75 chicken males of Ross line (R) and 50 of Cobb Vantress line (CV). The birds were weighed on days 1, 10, 20, 30, and 40 of age. The oxyhemoglobin saturation was measured, and then, after slaughtering, the ventricle right/total ventricle ratio (VD/VT) in 25 R and 15 CV chicks on days 20, 30 and 40 was calculated. Additionally, the conversion feed index was calculated. The VD/VT ratio for CV was 0.195 ± 0.12, 0.199 ± 0.013 and 0.188 ± 0.032, and in R was 0.205 ± 0.016, 0.179 ± 0.022 and 0.245 ± 0.042 on days 20, 30 and 40 respectively, with statistical difference between lines (p<0.05). The oxyhemoglobin saturation varied between 92.06 and 95.75% without statistical difference between lines. CV chicks were heavier than R (p<0.05) until day 30. It is concluded that in the greatest period of growth, the Cobb Vantress line showed higher body weights and major VD/VT ratio, while oxygen saturation was similar to that of chicken in the Ross line, being these values within the expected values for broilers.El estudio tuvo por objetivo determinar la relación entre el peso, saturación de la oxihemoglobina y la relación ventrículo derecho / ventrículo total (VD/VT) entre dos líneas comerciales de carnes de pollo a nivel del mar. Se utilizaron 75 pollos machos de la línea Ross (R) y 45 de la línea Cobb Vantress (CV). Las aves se pesaron en el día 1, 10, 20 30 y 40 de edad. Se determinó la saturación de la oxihemoglobina, y luego del sacrificio, se calculó la relación ventrículo derecho/ventrículo total (VD/VT) en 25 pollos R y 15 CV los días 20, 30 y 40. Adicionalmente, se calculó el índice de conversión alimenticia. La relación VD/VT para CV fue de 0.195 ± 0.12, 0.199 ± 0.013 y 0.188 ± 0.032 y en R de 0.205 ± 0.016, 0.179 ± 0.022 y 0.245 ± 0.042 a los 20, 30 y 40 días, respectivamente, con diferencias estadísticas entre líneas (p<0.05). La saturación de oxihemoglobina varió entre 92.06 y 95.75% sin diferencias estadísticas entre líneas. Los pollos CV fueron más pesados que R (p<0.05) hasta el día 30. Se concluye que en la etapa de mayor crecimiento, la línea Cobb Vantress tuvo mayor peso y una mayor relación VD/VT, mientras que la saturación de oxihemoglobina fue similar a la línea Ross, encontrándose estos valores dentro de los parámetros esperados para pollos de engorde

Impact of intrapartum antimicrobial prophylaxis upon the intestinal microbiota and the prevalence of antibiotic resistance genes in vaginally delivered full-term neonates

Background: Disturbances in the early establishment of the intestinal microbiota may produce important implications for the infant's health and for the risk of disease later on. Different perinatal conditions may be affecting the development of the gut microbiota. Some of them, such as delivery mode or feeding habits, have been extensively assessed whereas others remain to be studied, being critical to identify their impact on the microbiota and, if any, to minimize it. Antibiotics are among the drugs most frequently used in early life, the use of intrapartum antimicrobial prophylaxis (IAP), present in over 30% of deliveries, being the most frequent source of exposure. However, our knowledge on the effects of IAP on the microbiota establishment is still limited. The aim of the present work was to evaluate the impact of IAP investigating a cohort of 40 full-term vaginally delivered infants born after an uncomplicated pregnancy, 18 of which were born from mothers receiving IAP. Results: Fecal samples were collected at 2, 10, 30, and 90 days of age. We analyzed the composition of the fecal microbiota during the first 3 months of life by 16S rRNA gene sequencing and quantified fecal short chain fatty acids by gas chromatography. The presence of genes for resistance to antibiotics was determined by PCR in the samples from 1-month-old infants. Our results showed an altered pattern of intestinal microbiota establishment in IAP infants during the first weeks of life, with lower relative proportions of Actinobacteria and Bacteroidetes and increased of Preoteobacteria and Firmicutes. A delay in the increase on the levels of acetate was observed in IAP infants. The analyses of specific antibiotic resistance genes showed a higher occurrence of some beta-lactamase coding genes in infants whose mothers received IAP. Conclusions: Our results indicate an effect of IAP on the establishing early microbiota during the first months of life, which represent a key moment for the development of the microbiota-induced host homeostasis. Understanding the impact of IAP in the gut microbiota development is essential for developing treatments to minimize it, favoring a proper gut microbiota development in IAP-exposed neonates

Syndrome of hiperinfection by Strongyloides stercoralis

Se presenta el caso de una estrongiloidiasis diseminada en una paciente con tratamiento crónico de corticoides y una tumoración en región bulbar, que cursa con síndrome de distrés respiratorio agudo y lesiones dérmicas, aislándose la larva en el aspirado de secresión bronquial y biopsia de piel.It is showed a disseminated strongyloidiasis in a patient under chronic treatment with corticosteroids and a bulbar tumor, with acute respiratory distress syndrome and skin lesions, and isolation of the larva in bronchial secretion aspirate and skin biopsy

Predicting potential distribution and identifying priority areas for conservation of the Yellow-tailed Woolly Monkey (Lagothrix flavicauda) in Peru

Species distribution models (SDMs) provide conservationist with spatial distributions estimations of priority species. Lagothrix flavicauda (Humboldt, 1812), commonly known as the Yellow-tailed Woolly Monkey, is one of the largest primates in the New World. This species is endemic to the montane forests of northern Peru, in the departments of Amazonas, San Martín, Huánuco, Junín, La Libertad, and Loreto at elevation from1,000 to 2,800 m. It is classified as “Critically Endangered” (CR) by the International Union for Conservation of Nature (IUCN) as well as by Peruvian legislation. Furthermore, it is listed in Appendix I of the Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES). Research on precise estimates of its potential distribution are scare. Therefore, in this study we modeled the potential distribution area of this species in Peru, the model was generated using the MaxEnt algorithm, along with 80 georeferenced occurrence records and 28 environmental variables. The total distribution (high, moderate, and low) for L. flavicauda is 29,383.3 km2, having 3,480.7 km2 as high potential distribution. In effect, 22.64 % (6,648.49 km2) of the total distribution area of L. flavicauda is found within Natural Protected Areas (NPAs), with the following categories representing the largest areas of distribution: Protected Forests (1,620.41 km2), Regional Conservation Areas (1,976.79 km2), and Private Conservation Areas (1,166.55 km2). After comparing the predicted distribution with the current NPAs system, we identified new priority areas for the conservation of the species. We, therefore, believe that this study will contribute significantly to the conservation of L. flavicauda in Peru

Community-Acquired Pneumococcal Pneumonia in Virologically Suppressed HIV-Infected Adult Patients: A Matched Case-Control Study

Background: The study aimed to investigate whether the clinical presentations and outcomes (length of stay, ICU admission, and 30-day mortality) of pneumococcal pneumonia in virologically suppressed patients who were HIV-infected on ART with a CD4+ T-cell count > 350 cells/mm3 are comparable to those seen in patients with HIV, using a case-control design. Methods: A case-control study was carried out in Hospital Clinic, Barcelona, Spain (2001-2016). Control patients were matched by age (±10 years), sex, comorbidities, and pneumonia diagnosis in the same calendar period. Clinical presentation and outcomes of pneumococcal pneumonia in patients who were and were not infected with HIV were compared. Results: Pneumococcal pneumonia was studied in 50 cases (HIV infection) and 100 control patients (non-HIV infection). Compared with the control patients, case patients had higher rates of influenza (14% vs 2%, P = .007) and pneumococcal vaccination (10% vs 1%, P = .016). The group of cases also presented a higher rate of coinfection with hepatitis B virus (6% vs 0%, P = .036). Both groups presented similar ICU admission (18% vs 27%, P = .22), need for mechanical ventilation (12% vs 8%; P = .43), length of stay (7 days vs 7 days, P = .76), and 0% of 30-day mortality. No evidence was found of a more severe presentation or a worse clinical outcome in cases than in control patients. Conclusions: Pneumococcal pneumonia episodes requiring hospitalization in virologically suppressed patients with HIV with > 350 CD4+ T-cell count/mm3 were neither more severe nor had worse prognosis compared with uninfected patients. These results support the fact that such patients do not need treatment, admission, or care sites different to the general population

The comorbidity burden of type 2 diabetes mellitus: patterns, clusters and predictions from a large English primary care cohort

Background: Presence of additional chronic conditions has significant impact on the treatment and management of type-2 diabetes (T2DM). Little is known about the patterns of comorbidities in this population. The aims of this study are to quantify comorbidity patterns in people with T2DM, to estimate the prevalence of six chronic conditions in 2027 and to identify clusters of similar conditions. Methods: We used the Clinical Practice Research Datalink (CPRD) linked with the Index of Multiple Deprivation (IMD) data to identify patients diagnosed with T2DM between 2007 and 2017. 102,394 people met the study inclusion criteria. We calculated the crude and age-standardised prevalence of 18 chronic conditions present at and after the T2DM diagnosis. We analysed longitudinally the 6 most common conditions and forecasted their prevalence in 2027 using linear regression. We used agglomerative hierarchical clustering to identify comorbidity clusters. These analyses were repeated on subgroups stratified by gender and deprivation. Results: More people living in the most deprived areas had ≥1 comorbidities present at the time of diagnosis (72% of females; 64% of males) compared to the most affluent areas (67% of females; 59% of males). Depression prevalence increased in all strata, and was more common in the most deprived areas. Depression was predicted to affect 33% of females and 15% of males diagnosed with T2DM in 2027. Moderate clustering tendencies were observed, with concordant conditions grouped together and some variations between groups of different demographics. Conclusions: Comorbidities are common in this population and high between-patient variability in comorbidity patterns emphasises the need for patient-centred healthcare. Mental health is a growing concern and there is a need for interventions that target both physical and mental health in this population

History of Periodontitis Diagnosis and Edentulism as Predictors of Cardiovascular Disease, Stroke, and Mortality in Postmenopausal Women

BACKGROUND: Few studies have reported associations between periodontitis and cardiovascular disease (CVD) risk in older women, which is the objective of the present investigation. METHODS AND RESULTS: Participants were 57 001 postmenopausal women ages 55 to 89 years (mean 68 years; \u3e 85% 60 and older) who were enrolled (1993-1998) in the Women\u27s Health Initiative Observational Study, and were without known CVD when history of periodontitis and edentulism was assessed by questionnaire at study Year-5 (1998-2003). There were 3589 incident CVD events and 3816 total deaths during a mean follow-up of 6.7 years. In multivariable analysis, periodontitis was not associated with CVD events, but was associated with higher total mortality (hazard ratio (HR)=1.12, 95% CI: 1.05-1.21). Edentulism was associated with higher age- and smoking-adjusted risks of CVD (HR=1.42, 95% CI: 1.27-1.59) and mortality (HR=1.47, 95% CI: 1.32-1.63). Further adjustment eliminated the association with CVD, but mortality remained significantly increased (HR=1.17, 95% CI: 1.02-1.33). Stratification on age, race-ethnicity, smoking, and diabetes mellitus yielded comparable results; however, edentulism was more strongly associated with CVD in women reporting \u3e /=1 dental visit (HR=1.57) compared with (HR 1.03, interaction P=0.004) annually. CONCLUSIONS: In community-dwelling older women, edentulism was associated with increased risks of CVD and total mortality, and presence of periodontitis, which is more prevalent than edentulism, was associated with 17% higher mortality rate. These findings suggest that improving periodontal condition of the general population could reduce overall mortality